TENAX THERAPEUTICS, INC. Public Float
TENAX THERAPEUTICS, INC. (TENX) had Public Float of $23.84 million as of 2025-06-30, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-10
- 2025-06-30: Entity Public Float $23.84M.
- 2024-06-30: Entity Public Float $5.89M.
- 2023-06-30: Entity Public Float $7.03M.
- 2022-06-30: Entity Public Float $5.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $23.84M 10-K · filed 2026-03-10 |
| 2024-06-30 | $5.89M 10-K · filed 2025-03-25 |
| 2023-06-30 | $7.03M 10-K · filed 2024-03-28 |
| 2022-06-30 | $5.00M 10-K · filed 2023-03-31 |
| 2021-06-30 | $30.56M 10-K · filed 2022-03-29 |
| 2020-06-30 | $9.10M 10-K/A · filed 2021-04-16 |
| 2019-06-30 | $9.17M 10-K · filed 2020-03-30 |
| 2018-06-30 | $9.05M 10-K · filed 2019-04-01 |
| 2017-06-30 | $20.74M 10-K · filed 2018-04-02 |
| 2016-06-30 | $68.59M 10-K · filed 2017-03-16 |
| 2015-06-30 | $89.16M 10-KT · filed 2016-03-14 |
| 2014-10-31 | $95.68M 10-K · filed 2015-07-14 |
| 2014-04-30 | $19.68M 10-K · filed 2014-07-29 |
| 2012-10-31 | $29.47M 10-K · filed 2013-06-26 |
| 2012-07-20 | $41.56M 10-K · filed 2012-07-25 |
| 2011-12-12 | $42.43M 10-Q · filed 2011-12-15 |
| 2011-09-19 | $42.43M 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |